Stay updated with breaking news from Cost Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Magic mushrooms for depression. $1 hearing aids. Meds for 85 percent less. These are just a few of the advances these healthcare disruptors are engineering.
Excited physicians discuss the healthcare disruptors driving rapid change in the industry, such as fixed-profit pharmacy companies, AI in ICU therapeutics and more.
The Mark Cuban Cost Plus Drug Company, an online pharmacy dedicated to increasing access to lower-cost prescriptions, is partnering with Coherus Biosciences to distribute Yusimry, a biosimilar referencing Humira. It’s the first time the pharmacy has added a biosimilar to its list of drugs.
Coherus BioSciences’ adalimumab biosimilar, Yusimry, will make its debut in the U.S. marketplace this summer at an 85% discount compared with the originator Humira, according to the manufacturer.
– YUSIMRY™ will be the first biologic product offered by the Mark Cuban Cost Plus Drug Company – – YUSIMRY will be available on costplusdrugs.com... | June 1, 2023